ArticleBiological trace element research2026
Modulatory Effects of Essential Trace Elements on Glycemic Biomarkers in Toxic Metal-Induced Associated Diabetes.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Trace elements play a vital role in maintaining metabolic health by regulating glucose metabolism, enhancing insulin sensitivity, and supporting antioxidant defense. Moreover, they act as protective shields against toxic metal-induced oxidative stress, where even slight imbalances can shift the body from metabolic harmony to diabetes progression. This prospective case-control study was conducted at the Department of Biochemistry in collaboration with the Department of General Medicine at the North Indian Tertiary Care Centre. This study included 473 newly diagnosed type 2 diabetic patients (T2DM) and 303 controls. Serum toxic and trace elements were analyzed using inductively coupled plasma mass spectrometry. HbA1c was measured using ion-exchange high-performance liquid chromatography, while fasting serum insulin and glucose levels were measured using Cobas 6000, Roche Diagnostics to calculate insulin resistance and beta-cell dysfunction. Toxic elements (Nickel and Arsenic) and trace elements (Selenium, Molybdenum, Chromium, and Copper) were significantly elevated, while Manganese (Mn) was significantly reduced in the T2DM group compared to the controls (p < 0.0001, respectively). Nickel (Ni) and arsenic (As) were independently associated with HbA1c and insulin resistance in multivariate analysis. Among the trace elements, only Mn remained independently but was negatively associated with HbA1c. With β-cell function as the outcome, As remained negatively associated, and Mn remained positively associated. Gaussian process classifier and Bayesian kernel machine regression analysis further verified that Mn antagonizes diabetes risk associated with Ni and As exposures. Targeting trace element homeostasis, particularly enhancing Mn status, may open new avenues for the prevention and therapeutic intervention of T2DM.
Indexed as
Identifiers
41965498What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.